Larkin J, Del Vecchio M, Mandala M, Gogas H, et al. Adjuvant Nivolumab Versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results From CheckMate 238. Clin Cancer Res 2023 Apr 14:CCR-22-3145. doi: 10.1158/1078-0432.CCR-22-3145.
PMID: 37058595